Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Günter Derigs"'
Autor:
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, Stephan Kaun, Anke Morgner, Georg Hess, Thomas Elter, Nikolas von Bubnoff, Martin Dreyling, Mark Ringhoffer, Stefan W. Krause, Günter Derigs, Beate Klimm, D. Niemann, Kristina Fritsch, Jürgen Finke, Gerald Illerhaus
Publikováno v:
Haematologica, Vol 98, Iss 5 (2013)
High-dose chemotherapy followed by autologous stem cell transplantation has been shown to be feasible and highly effective in newly diagnosed primary central nervous system lymphoma. In this retrospective multicenter study, we investigated prognosis
Externí odkaz:
https://doaj.org/article/7c9b5dcb86444f11bffc7618729dc3c3
Autor:
Uwe M. Martens, Jörg Westermann, Peter Paschka, Helmut R. Salih, Richard Greil, Thomas Südhoff, Konstanze Döhner, Julia Krzykalla, Thomas Kindler, Bernd Hertenstein, Verena I. Gaidzik, Wolfgang Herr, Michael Girschikofsky, Alexander Burchardt, Thomas Schroeder, Gerhard Held, Michael Heuser, Katharina Götze, Gerald Wulf, Roland Schroers, Daniela Weber, Richard F. Schlenk, Elisabeth Lange, Doris Kraemer, Hartmut Döhner, Axel Benner, Michael Lübbert, Mark Ringhoffer, Arnold Ganser, Felicitas Thol, Hans-Günter Derigs, Martin Grießhammer, Heinz-August Horst, Lore Marretta, Jürgen Krauter, Walter Fiedler, Hans Salwender, Dominik Wolf
Publikováno v:
Blood. 133:840-851
Patients with acute myeloid leukemia (AML) and a FLT3 internal tandem duplication (ITD) have poor outcomes to current treatment. A phase 2 hypothesis-generating trial was conducted to determine whether the addition of the multitargeted kinase inhibit
Autor:
Roger von Moos, Felicitas Scholten, Mark-Oliver Zahn, Sandro Anchisi, Hans-Günter Derigs, H. Kröning, Josef Thaler, Stefanie Pederiva, Pierre Oliver Bohanes, Birgit Gruenberger, Christine Windemuth-Kieselbach, Gudrun Piringer, Ralf Hofheinz
Publikováno v:
Journal of Clinical Oncology. 39:e15570-e15570
e15570 Background: The anti-angiogenic fusion protein aflibercept targets VEGF-A, VEGF-B and PIGF. It is approved in combination with FOLFIRI for treatment of mCRC previously treated with an oxaliplatin-containing regimen. We evaluated the influence
Autor:
Katharina Götze, Thomas Heinicke, Arnold Ganser, M. Wattad, Thomas Kindler, Michael Girschikofsky, K Döhner, Gudrun Göhring, Gerald Wulf, Peter Brossart, Bernd Hertenstein, Cornelia Rudolph, Peter Paschka, Verena I. Gaidzik, Richard F. Schlenk, Heinz-August Horst, Daniela Weber, Felicitas Thol, S Erhardt, Michael Heuser, Helmut R. Salih, Hartmut Döhner, Michael Lübbert, Joerg Westermann, Veronica Teleanu, Gabriele Nagel, Walter Fiedler, Jürgen Krauter, Andrea Kündgen, Hans-Günter Derigs, Ella Fromm, Doris Kraemer, Lars Bullinger
Publikováno v:
Annals of Hematology
We describe genetic and clinical characteristics of acute myeloid leukemia (AML) patients according to age from an academic population-based registry. Adult patients with newly diagnosed AML at 63 centers in Germany and Austria were followed within t
Autor:
Timo Gaiser, Matthias Schwarzbach, Hans-Günter Derigs, Antonia Dimitrakopoulou-Strauss, Ulrike I. Attenberger, Ulrich Ronellenfitsch, Ioannis Karampinis, Bernd Kasper, Jens Jakob, Kai Nowak, Christos Sachpekidis, Lothar R. Pilz, Peter Hohenberger
Publikováno v:
Cancers
Volume 11
Issue 6
Cancers, Vol 11, Iss 6, p 790 (2019)
Volume 11
Issue 6
Cancers, Vol 11, Iss 6, p 790 (2019)
The outcome of high-risk soft tissue sarcoma (STS) is poor with radical surgery being the only potentially curative modality. Pazopanib is a multikinase inhibitor approved for the treatment of metastatic STS. Herein, in terms of the German Interdisci
Autor:
Christos, Sachpekidis, Ioannis, Karampinis, Jens, Jakob, Bernd, Kasper, Kai, Nowak, Lothar, Pilz, Ulrike, Attenberger, Timo, Gaiser, Hans-Günter, Derigs, Matthias, Schwarzbach, Peter, Hohenberger, Antonia, Dimitrakopoulou-Strauss, Ulrich, Ronellenfitsch
Publikováno v:
Cancers
The outcome of high-risk soft tissue sarcoma (STS) is poor with radical surgery being the only potentially curative modality. Pazopanib is a multikinase inhibitor approved for the treatment of metastatic STS. Herein, in terms of the German Interdisci
Autor:
Richard F, Schlenk, Daniela, Weber, Walter, Fiedler, Helmut R, Salih, Gerald, Wulf, Hans, Salwender, Thomas, Schroeder, Thomas, Kindler, Michael, Lübbert, Dominik, Wolf, Jörg, Westermann, Doris, Kraemer, Katharina S, Götze, Heinz-August, Horst, Jürgen, Krauter, Michael, Girschikofsky, Mark, Ringhoffer, Thomas, Südhoff, Gerhard, Held, Hans-Günter, Derigs, Roland, Schroers, Richard, Greil, Martin, Grießhammer, Elisabeth, Lange, Alexander, Burchardt, Uwe, Martens, Bernd, Hertenstein, Lore, Marretta, Michael, Heuser, Felicitas, Thol, Verena I, Gaidzik, Wolfgang, Herr, Julia, Krzykalla, Axel, Benner, Konstanze, Döhner, Arnold, Ganser, Peter, Paschka, Hartmut, Döhner
Publikováno v:
Blood. 133(8)
Patients with acute myeloid leukemia (AML) and a
Autor:
Ellen K. Ritchie, Judith A. Fox, Cyrus R. Mehta, Olatoyosi Odenike, Andrew H. Wei, Renee Ward, Gail J. Roboz, Michael Heuser, Norbert Vey, Gary Acton, Stephen A. Strickland, Elias Jabbour, Jeffrey E. Lancet, Arnaud Pigneux, Adam R. Craig, Donna E. Hogge, Gary J. Schiller, Gianluca Gaidano, Michael Craig, Violaine Havelange, Bayard L. Powell, Lloyd E. Damon, Xavier Thomas, Heinz A. Horst, Jennifer A. Smith, Christian Recher, Harry P. Erba, Robert K. Stuart, Angelo Michele Carella, Farhad Ravandi, Hagop M. Kantarjian, Jorge E. Cortes, Johan Maertens, Hans Günter Derigs, Virginia M. Klimek, Hamid Sayar
Publikováno v:
The Lancet Oncology, Vol. 16, no.9, p. 1025-1036 (2015)
The Lancet. Oncology, vol 16, iss 9
The Lancet. Oncology, vol 16, iss 9
BACKGROUND: Safe and effective treatments are urgently needed for patients with relapsed or refractory acute myeloid leukaemia. We investigated the efficacy and safety of vosaroxin, a first-in-class anticancer quinolone derivative, plus cytarabine in
Autor:
Anja Stölzle, Verena I. Gaidzik, Heinz Kirchen, Sabine Kayser, Marie von Lilienfeld-Toal, Arnold Ganser, Daniela Späth, Wolfram Brugger, Jürgen Krauter, Hans Günter Derigs, Richard F. Schlenk, Michael Girschikofsky, Volker Runde, Richard Greil, Lars Bullinger, Mohammed Wattad, Maria-Veronica Teleanu, Stephan Kremers, Andrea Kuendgen, Aruna Raghavachar, Peter Paschka, Brigitte Schlegelberger, Hartmut Döhner, Andreas L. Petzer, Michael Heuser, Gerhard Heil, Gudrun Goehring, Mark Ringhoffer, Konstanze Döhner, Helmut R. Salih
Publikováno v:
Blood. 121:4769-4777
In this study, we evaluated the frequency and prognostic impact of DNMT3A mutations (DNMT3A(mut)) in 1770 younger adult patients with acute myeloid leukemia (AML) in the context of other genetic alterations and the European LeukemiaNet (ELN) classifi
Autor:
Kai Nowak, Ulrich Ronellenfitsch, Stefan Fröhling, Bernd Kasper, Timo Gaiser, Gerlinde Egerer, Jens Jakob, Antonia Dimitrakopoulou-Strauss, Ulrike I. Attenberger, Hans-Günter Derigs, Peter Hohenberger, Matthias Schwarzbach, Lothar R. Pilz
Publikováno v:
BMJ Open
Introduction For resectable soft tissue sarcoma (STS), radical surgery, usually combined with radiotherapy, is the mainstay of treatment and the only potentially curative modality. Since surgery is often complicated by large tumour size and extensive